CD19 and hepatocellular carcinoma: Furthermore, significantly greater numbers of CD19+CD5+PD-L1+ (Fig. S7G) and CD19+IgM+IgD+ B cells (Fig. S7H) were observed in the inflamed HCC subtype than in the non-inflamed HCC subtype.